Christine Lu

Professor Christine Lu is a globally recognized academic in clinical pharmacy and pharmacoeconomics, serving as Chair of Clinical Pharmacy at the Sydney Pharmacy School, University of Sydney. She holds a dual appointment at the Northern Sydney Local Health District and has held previous roles at Harvard Medical School and Harvard Pilgrim Health Care Institute. Her expertise spans health policy, genomic medicine, and pharmacoepidemiology, with a focus on optimizing medication use and outcomes in diverse populations.

Education & Career: Dr. Lu earned her MSc (Biopharmaceuticals) and PhD from the University of New South Wales and completed postdoctoral training at Harvard Medical School. She transitioned from academic roles in the U.S. to the University of Sydney in 2023.

Research Interests: Her work addresses critical issues in healthcare systems, including:

• Impact of health policies on medication access and outcomes
• Genomic healthcare (e.g., pharmacogenomics) and ethical implications
• Quality use of high-cost medicines and biosimilars
• Real-world evidence generation using linked datasets

Her current projects include national analyses of precision medicine and biosimilar utilization in Australia.

Publications & Impact: Over 200 peer-reviewed articles reflect her focus on disparities in chronic disease outcomes, pharmacogenetic testing, and AI-driven predictive analytics. Recent work highlights disparities in heart failure mortality among diabetes patients and the utility of genomic testing in pediatric populations.

Awards & Recognition: Recipient of the Genomic Innovator Award (NIH, 2020-2025), Robert H. Ebert Career Development Award (Harvard, 2018-2020), and the Caroline Miles Award (University of Oxford, 2016).

Grants & Mentorship: Leads postgraduate research scholarships in medicines policy and outcomes research. Current advisees include Harry LE (optimizing psychotropic use in dementia) and Benson YIU (biosimilar utilization analysis). She chairs multidisciplinary teams at the Sydney Pharmacy School and collaborates internationally on implementation science initiatives like the IMPULSS program for Lynch syndrome screening.

Labs & Collaborations: Active in translational research through the Sydney Pharmacy School’s Clinical Pharmacy Unit, focusing on real-world data applications and health technology assessment. Collaborates with global networks including ISPOR and the Harvard Club of Australia.